Observational studyCardiovascular diabetology2020

The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors.

Ann Wan-Chin Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.